Human protein MxA restricts H5N1, but virus mutations raise alarms

Human MxA protein suppresses mammalian H5N1 virus replication, but emerging mutations may enable partial evasion, raising concerns for human transmission.

CDC Addresses Rebound of Mycoplasma Pneumonia in Kids

In the fall of 2023, emergency department (ED)-related visits for Mycoplasma pneumoniae in children rebounded somewhat from a lull during the COVID-19 pandemic, but the

February 24, 2024

Study may open up new ways of approaching metabolic diseases

A study led by the University of Barcelona and the Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders (CIBERDEM) reveals how a new

February 12, 2024

Pennsylvania Names Ophelia First Virtual-First Opioid Use Disorder COE

What You Should Know: – Ophelia, a leading provider of virtual care for opioid use disorder (OUD), has been designated as a Center of Excellence

April 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.